Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Devonian Health Group Inc V.GSD

Alternate Symbol(s):  DVHGF

Healthcare
Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. It is also involved in the development of value-added products for dermo-cosmetics and the distribution of pharmaceutical products through its subsidiary. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company's cosmeceutical products include R-Spinasome and Purgenesis.


TSXV:GSD - Post by User

Devonian Health Group Inc > S.O.S
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(276)
•••
Comment by wallywagonon Apr 16, 2021 9:05am
120 Views
Post# 33009815

RE:S.O.S

RE:S.O.SAgree Totally W5 !!! At least maybe the word will get out for GSD with this firm. Lord know the
President did a horrible job. Unfortunately, too many insiders been holding this a long time.
CEO needs to go back in the LAB. He's an expert on that BUT, he shouldn't promote when he doesn't have deals done.Where is the Brokerage Firm with bought financing??? Should have happened by now. They need money for Phase 3 testing. Either way He Needs To Go!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities